FDA Inspection 978315 — American Red Cross Biomedical Services Northern New England Region
The FDA completed an inspection of American Red Cross Biomedical Services Northern New England Region on July 15, 2016 in Burlington, VT. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 15, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Burlington, VT (United States)